Cases & Deals

JumpStart invests in CerviLenz

Clients JumpStart Inc.

Jones Day counseled JumpStart Inc. in its investment in CerviLenz, Inc., a manufacturer and marketer of a patented, FDA-cleared device to predict preterm birth risk in pregnant women.